BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9306058)

  • 1. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints.
    Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD
    Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine TIMP-1 and TIMP-2: identification, activity and cellular sources.
    Clegg PD; Coughlan AR; Carter SD
    Equine Vet J; 1998 Sep; 30(5):416-23. PubMed ID: 9758100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-2 and -9 are activated in joint diseases.
    Clegg PD; Carter SD
    Equine Vet J; 1999 Jul; 31(4):324-30. PubMed ID: 10454092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
    Flannery CR; Little CB; Caterson B; Hughes CE
    Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular studies of matrix metalloproteinases and tissue inhibitors of metalloproteinases in equine joints.
    Clegg PD; Radford AD; Carter SD
    Vet J; 1999 May; 157(3):336-8. PubMed ID: 10328846
    [No Abstract]   [Full Text] [Related]  

  • 6. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
    Clegg PD; Coughlan AR; Riggs CM; Carter SD
    Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and identification of proteinases and proteinase inhibitors synthesized by temporomandibular joint disc cells.
    Kapila S; Lee C; Richards DW
    J Dent Res; 1995 Jun; 74(6):1328-36. PubMed ID: 7629341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase inhibitors augment the production of pro-matrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes.
    Ito A; Nose T; Takahashi S; Mori Y
    FEBS Lett; 1995 Feb; 360(1):75-9. PubMed ID: 7875305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular sources of proteolytic enzymes in equine joints.
    Spiers S; May SA; Bennett D; Edwards GB
    Equine Vet J; 1994 Jan; 26(1):43-7. PubMed ID: 8143663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and partial characterization of three calcium- and zinc-independent gelatinases constitutively present in human circulation.
    Makowski GS; Ramsby ML
    Biochem Mol Biol Int; 1998 Dec; 46(5):1043-53. PubMed ID: 9861458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
    Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
    Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone.
    Rao VH; Bridge JA; Neff JR; Schaefer GB; Buehler BA; Vishwanatha JK; Pollock RE; Nicolson GL; Yamamoto M; Gokaslam ZL
    Clin Exp Metastasis; 1995 Nov; 13(6):420-6. PubMed ID: 7586800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
    Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
    J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes.
    Sasaki K; Hattori T; Fujisawa T; Takahashi K; Inoue H; Takigawa M
    J Biochem; 1998 Mar; 123(3):431-9. PubMed ID: 9538225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
    Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
    Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
    Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA
    Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production, purification and characterization of canine prostromelysin.
    Bayne EK; Hutchinson NI; Walakovits LA; Donatelli S; MacNaul KL; Harper CF; Cameron P; Moore VL; Lark MW
    Matrix; 1992 Jun; 12(3):173-84. PubMed ID: 1406451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of N-carboxyalkyl peptides to the inhibition and affinity purification of the porcine matrix metalloproteinases collagenase, gelatinase, and stromelysin.
    Stack MS; Emberts CG; Gray RD
    Arch Biochem Biophys; 1991 Jun; 287(2):240-9. PubMed ID: 1654808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis.
    Pollitt CC; Pass MA; Pollitt S
    Equine Vet J Suppl; 1998 Sep; (26):119-24. PubMed ID: 9932102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade.
    Dreier R; Grässel S; Fuchs S; Schaumburger J; Bruckner P
    Exp Cell Res; 2004 Jul; 297(2):303-12. PubMed ID: 15212936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.